These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20804723)

  • 1. Multi-step oxidations catalyzed by cytochrome P450 enzymes: Processive vs. distributive kinetics and the issue of carbonyl oxidation in chemical mechanisms.
    Guengerich FP; Sohl CD; Chowdhury G
    Arch Biochem Biophys; 2011 Mar; 507(1):126-34. PubMed ID: 20804723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.
    Guengerich FP
    Chem Res Toxicol; 2001 Jun; 14(6):611-50. PubMed ID: 11409933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the three-step steroid aromatase reaction of human cytochrome P450 19A1.
    Sohl CD; Guengerich FP
    J Biol Chem; 2010 Jun; 285(23):17734-43. PubMed ID: 20385561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of aromatase and other cytochrome P450 mediated deformylation reactions.
    Korzekwa KR; Trager WF; Mancewicz J; Osawa Y
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):367-73. PubMed ID: 8476750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cytochrome P450 substrate oxidation: MiniReview.
    Guengerich FP
    J Biochem Mol Toxicol; 2007; 21(4):163-8. PubMed ID: 17936929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
    Spracklin DK; Hankins DC; Fisher JM; Thummel KE; Kharasch ED
    J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate-limiting steps in cytochrome P450 catalysis.
    Guengerich FP
    Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of N-Nitrosoalkylamines by human cytochrome P450 2A6: sequential oxidation to aldehydes and carboxylic acids and analysis of reaction steps.
    Chowdhury G; Calcutt MW; Guengerich FP
    J Biol Chem; 2010 Mar; 285(11):8031-44. PubMed ID: 20061389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 reconstitution systems.
    Yamazaki H; Shimada T
    Methods Mol Biol; 2006; 320():61-71. PubMed ID: 16719374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
    Peng HM; Raner GM; Vaz AD; Coon MJ
    Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde reduction by cytochrome P450.
    Amunom I; Srivastava S; Prough RA
    Curr Protoc Toxicol; 2011 May; Chapter 4():Unit4.37. PubMed ID: 21553396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: evidence for major roles by cytochromes P450 2A6 and 2E1.
    Duescher RJ; Elfarra AA
    Arch Biochem Biophys; 1994 Jun; 311(2):342-9. PubMed ID: 8203896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human.
    Marini S; Grasso E; Longo V; Puccini P; Riccardi B; Gervasi PG
    Xenobiotica; 2003 Jan; 33(1):1-11. PubMed ID: 12519690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Cytochrome P450-Catalyzed Oxidations.
    Guengerich FP
    ACS Catal; 2018 Dec; 8(12):10964-10976. PubMed ID: 31105987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.